On April 8, 2019, Corizon Health announced plans to expand a pilot medication assisted treatment (MAT) program for inmates with opioid use disorder. The pilot, which started in 2018, took place with the Philadelphia Department of Prisons, which contracts with Corizon to provide jail medical services. The program provides treatment with buprenorphine tablets during incarceration. All inmates receiving MAT are offered cognitive behavioral therapy. Upon release, the program participants are provided with a transition dosage package and referrals to continue community-based treatment. The prison staff also helps eligible inmates apply for Medicaid. The Corizon team networks with treatment programs . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.